4.7 Article

DNA targeting half sandwich Ru(ii)-p-cymene-N boolean AND N complexes as cancer cell imaging and terminating agents: influence of regioisomers in cytotoxicity

Journal

DALTON TRANSACTIONS
Volume 50, Issue 3, Pages 979-997

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/d0dt03107k

Keywords

-

Funding

  1. Department of Science and Technology, Government of India [EMR/2017/000816]
  2. VIT University

Ask authors/readers for more resources

A library of half sandwich Ru(ii)-p-cymene-N<^>N complexes was synthesized using a convenient one pot protocol, showing significant potency and selectivity against cancer cell lines. The Ru(ii)-arene complexes exhibited excellent DNA binding efficacy and fluorescence properties, making them potential candidates for cancer theranostic treatment.
For diagnosing and annihilating cancer in the human body, herein, we have adopted a one pot convenient synthetic protocol to synthesize a library of half sandwich Ru(ii)-p-cymene-N<^>N complexes under continuous sonication and isolated their regioisomers by preparative thin layer chromatography followed by justification of stability using DFT. The present work has resulted in a library of ruthenium arene complexes and their isolated regioisomers following environmentally benign green processes and their screening of anticancer activity in terms of cytotoxicity and selectivity against cancer cell lines where [(eta(6)-p-cymene)RuCl{2-(5,6-dichloro-1H-benzo[d]imidazole-2-yl)quinolone}] (11j) has been elicited to be significantly more potent as well as selective in Caco-2 and HeLa cell lines than the normal HEK-293 cell line compared to cisplatin and it has even shown marked cytotoxicity against the more aggressive HT-29 colorectal cancer cell line being capable of producing oxidative stress or arresting the cell cycle. Moreover, these types of Ru(ii)-arene complexes exhibited excellent binding efficacy with DNA and the compounds [(eta(6)-p-cymene)RuCl{5-chloro-2-(6-(4-chlorophenyl)pyridin-2-yl)benzo[d]thiazole}]PF6 (8l4), [(eta(6)-p-cymene)Ru-2-(6-(benzofuran-2-yl)pyridin-2-yl)-5-chlorobenzo[d]thiazole (8l9) and [(eta(6)-p-cymene)RuCl{2-(6-nitro-1H-benzo[d]imidazol-2-yl)quinolone}]Cl (11f ') and might be applied for cancer theranostic treatment due to their good fluorescence properties and remarkable potency.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available